
- 1D
- 1W
- 1M
- 1Y
- 5Y
- YTD
About LAVA THERAPEUTICS NV
LAVA Therapeutics NV, formerly known as Lava Therapeutics BV, is a provider of biotechnology research and development services based in the Netherlands. The Company focuses of developing next generation Vdelta T cell engaging bispecific antibodies to fight cancer.
Stock Analysis

last close
$2.71
1-mo return
-4.1%
3-mo return
-25.9%
avg daily vol.
5.67T
52-week high
8.38
52-week low
2.28
market cap.
$65M
forward pe
-
annual div.
-
roe
-29.9%
ltg forecast
-
dividend yield
-
annual rev.
$5M
inst own.
55.5%